These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity. Heikkilä J; Nieminen MS Am Heart J; 1982 Aug; 104(2 Pt 2):464-72. PubMed ID: 7102533 [TBL] [Abstract][Full Text] [Related]
44. Ten-year mortality rate among patients in whom acute myocardial infarction was not confirmed in relation to clinical history and observations during hospital stay: experiences from the Göteborg Metoprolol Trial. Herlitz J; Karlson BW; Hjalmarson A Int J Cardiol; 1994 May; 44(3):217-24. PubMed ID: 8077067 [TBL] [Abstract][Full Text] [Related]
45. Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group. Am J Cardiol; 1985 Nov; 56(14):3G-9G. PubMed ID: 2865889 [TBL] [Abstract][Full Text] [Related]
46. Effect of very early intervention with metoprolol on myocardial infarct size. Boyle DM; Barber JM; McIlmoyle EL; Salathia KS; Evans AE; Cran G; Elwood JH; Shanks RG Br Heart J; 1983 Mar; 49(3):229-33. PubMed ID: 6338889 [TBL] [Abstract][Full Text] [Related]
47. A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction--the MEMO study. Everts B; Karlson B; Abdon NJ; Herlitz J; Hedner T J Intern Med; 1999 Feb; 245(2):133-41. PubMed ID: 10081516 [TBL] [Abstract][Full Text] [Related]
49. Early use of metoprolol and serum potassium in suspected acute myocardial infarction. Herlitz J; Hjalmarson A; Waagstein F Int J Cardiol; 1989 Feb; 22(2):169-75. PubMed ID: 2644175 [TBL] [Abstract][Full Text] [Related]
50. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794 [TBL] [Abstract][Full Text] [Related]
51. Similar risk reduction of death of extended-release metoprolol once daily and immediate-release metoprolol twice daily during 5 years after myocardial infarction. Herlitz J; Dellborg M; Karlson BW; Lindqvist J; Sandèn W; Svensson H; Sjölin M; Wedel H Cardiovasc Drugs Ther; 1999 Apr; 13(2):127-35. PubMed ID: 10372228 [TBL] [Abstract][Full Text] [Related]
52. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393 [TBL] [Abstract][Full Text] [Related]
53. Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group. Am J Cardiol; 1985 Nov; 56(14):23G-26G. PubMed ID: 3904390 [TBL] [Abstract][Full Text] [Related]
54. Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta-blocker at hospital discharge. Herlitz J; Dellborg M; Karlson BW; Lindqvist J; Wedel H Cardiovasc Drugs Ther; 2000 Dec; 14(6):589-95. PubMed ID: 11300359 [TBL] [Abstract][Full Text] [Related]
55. Prognosis during one year for patients with myocardial infarction in relation to the development of Q waves: experiences from the Miami trial. Herlitz J; Hjalmarson A; Karlson BW Clin Cardiol; 1990 Apr; 13(4):261-4. PubMed ID: 2190724 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of antiarrhythmic effect of metoprolol treatment after acute myocardial infarction: relationship between treatment responses and survival during a 3-year follow-up. Olsson G; Rehnqvist N Eur Heart J; 1986 Apr; 7(4):312-9. PubMed ID: 2424759 [TBL] [Abstract][Full Text] [Related]
57. Effect of metoprolol on early exercise-induced ST-segment changes and ventricular arrhythmias in patients with suspected acute myocardial infarction. Rønnevik PK; Gundersen T; Abrahamsen AM; Knutsen H; Woie L Int J Cardiol; 1989 Jan; 22(1):51-7. PubMed ID: 2647644 [TBL] [Abstract][Full Text] [Related]
58. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders. Benfield P; Clissold SP; Brogden RN Drugs; 1986 May; 31(5):376-429. PubMed ID: 2940080 [TBL] [Abstract][Full Text] [Related]
59. Effect of early metoprolol injection followed by oral dosage on CK-MB release, and myocardial function in suspected acute myocardial infarction. A double-blind controlled study. Halinen MO; Palomäki P; Kuikka J; Länsimies E; Miettinen H; Penttilä I; Pyörälä K Cardiology; 1989; 76(3):180-92. PubMed ID: 2673511 [TBL] [Abstract][Full Text] [Related]
60. Acute intervention with metoprolol in myocardial infarction. Hjalmarson A Acta Med Scand Suppl; 1981; 651():177-84. PubMed ID: 7034473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]